Cassava Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1999
Selling, General & Admin	16.53	11.99	8.06	3.74	3.39	3.69	4.33	5.78	5.1	5.13	Upgrade
Research & Development	89.42	68.03	24.81	3.05	1.57	2.97	7.62	9.18	9.1	7.31	Upgrade
Other Operating Expenses	0	0	0	-0.35	0	0	0	0	0	0	Upgrade
Operating Expenses	105.96	80.02	32.87	6.45	4.96	6.66	11.95	14.96	14.2	12.43	Upgrade
Operating Income	-105.96	-80.02	-32.87	-6.45	-4.96	-6.66	-11.95	-14.96	-14.2	-12.43	Upgrade
Other Expense / Income	-8.74	-3.77	-0.48	-0.11	-0.33	-0.11	-0.04	-0.11	-0.06	-0.05	Upgrade
Pretax Income	-97.22	-76.25	-32.39	-6.33	-4.63	-6.56	-11.91	-14.85	-14.15	-12.39	Upgrade
Net Income	-97.22	-76.25	-32.39	-6.33	-4.63	-6.56	-11.91	-14.85	-14.15	-12.39	Upgrade
Shares Outstanding (Basic)	42	40	39	26	17	11	7	7	6	6	Upgrade
Shares Outstanding (Diluted)	42	40	39	26	17	11	7	7	6	6	Upgrade
Shares Change	4.30%	2.02%	50.95%	49.93%	63.00%	63.41%	0.26%	0.63%	0.19%	0.13%	Upgrade
EPS (Basic)	-2.32	-1.90	-0.82	-0.24	-0.27	-0.61	-1.82	-2.28	-2.17	-1.89	Upgrade
EPS (Diluted)	-2.32	-1.90	-0.82	-0.24	-0.27	-0.61	-1.82	-2.28	-2.17	-1.89	Upgrade
Free Cash Flow	-82.44	-80.23	-52.41	-5.02	-2.53	-4.77	-8.24	-12.31	-9.25	-9.63	Upgrade
Free Cash Flow Per Share	-1.97	-2.00	-1.33	-0.19	-0.14	-0.45	-1.26	-1.89	-1.43	-1.49	Upgrade
EBITDA	-95.69	-74.95	-31.85	-6.31	-4.57	-6.49	-11.84	-14.79	-14.1	-12.37	Upgrade
Depreciation & Amortization	1.53	1.3	0.53	0.02	0.06	0.07	0.07	0.06	0.05	0.02	Upgrade
EBIT	-97.22	-76.25	-32.39	-6.33	-4.63	-6.56	-11.91	-14.85	-14.15	-12.39	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).